The TNFR1 Antagonist Atrosimab Is Therapeutic in Mouse Models of Acute and Chronic Inflammation

Overview of attention for article published in Frontiers in immunology, July 2021

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 3 X users

Citations

dimensions_citation: 22 Dimensions

Readers on

mendeley: 61 Mendeley

Summary X Dimensions citations

So far, Dimensions has found 22 publications that cite this research output.

22

The most recent citing publications are shown below. View all 22 publications that cite this research output on Dimensions.

Cancer marker TNFRSF1A: From single‑cell heterogeneity of renal cell carcinoma to functional validation

Article in Oncology Letters (July 2024)

Proteomic insights uncover enhanced neurotherapeutic potential in conditioned mesenchymal stem cell-derived extracellular vesicles

Article in Extracellular Vesicle (June 2024)

Inflammatory liver diseases and susceptibility to sepsis

Article in Clinical Science (April 2024)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.